Last update May 16, 2019
The protection for infants whose mothers work in nuclear medicine services should be the same as that used for breastfeeding mothers who undergo scans or treatments with radionuclides (Almén 2017, Euratom 2014).
For these mothers, the period of halting breastfeeding or of avoiding close contact are calculated so that the infant is not exposed to more than 1 millisievert (1 mSv = 0.1 rem) of radiation (Alén 2017, ARSAC 2019, US.NCR 2016, ICRP 2008, Stabin 2000).
An adult receives between 5 and 10 mSv annually from environmental radiation.
AS A GENERAL STANDARD, any breastfeeding working mother whose infant can be exposed to more than 1 mSv (100 mrem) per year (<0.1 mSv per month) should have her workplace conditions adapted so that this does not occur (Almén 2017 , IAEA 2014).
SPECIFIC CASES (Alén 2017):
Following the appropriate general radiological protection measures, breastfeeding workers can handle drugs with TC 99m, due to the very low exposure, lower than the limits established for infants.
Despite following adequate general radiological protection measures, breast-feeding workers should not handle PET drugs or perform cyclotron operation and maintenance work, because exposure may exceed the limit established for the infant and beyond in the event of an accident.
In spite of following adequate general radiological protection measures, breastfeeding workers should not handle drugs with I-131, because exposure can widely exceed the limit established for the infant, and because iodine compounds are very volatile and are excreted in significant amounts in breastmilk.
Despite following adequate general radiological protection measures, breast-feeding workers should not handle alpha- and beta-emitting drugs, because, in the event of an accident, exposure is very high and may well exceed the limit established for the infant.
Breastfeeding workers should not carry out emergency work, including cleaning after heavy contamination.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM